نتائج البحث - Bhateja, Priyanka
- يعرض 1 - 10 نتائج من 10
-
1
-
2
-
3
-
4
A detailed smoking history and determination of MYC status predict response to checkpoint inhibitors in advanced non-small cell lung cancer حسب Chiu, Michelle, Lipka, Mary Beth, Bhateja, Priyanka, Fu, Pingfu, Dowlati, Afshin
منشور في 2020نص -
5
Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer حسب Bhateja, Priyanka, Chiu, Michelle, Wildey, Gary, Lipka, Mary Beth, Fu, Pingfu, Yang, Michael Chiu Lee, Ardeshir‐Larijani, Fatemeh, Sharma, Neelesh, Dowlati, Afshin
منشور في 2019نص -
6
Identification of Clinical and Socioeconomic Predictors of Adjuvant Therapy after Trans-Oral Robotic Surgery in Patients with Oropharyngeal Squamous Cell Carcinoma حسب Baliga, Sujith, Klamer, Brett, Jhawar, Sachin, Gamez, Mauricio, Mitchell, Darrion, Blakaj, Adriana, Grecula, John, Gardner, Ulysses, Dibs, Khaled, Old, Matthew, Seim, Nolan, Kang, Stephen, Carrau, Ricardo, Agrawal, Amit, Karivedu, Vidhya, Bhateja, Priyanka, Ozer, Enver, Rocco, James, Bonomi, Marcelo, Blakaj, Dukagjin
منشور في 2020نص -
7
T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma حسب Wang, Xuefeng, Muzaffar, Jameel, Kirtane, Kedar, Song, Feifei, Johnson, Matthew, Schell, Michael J, Li, Jiannong, Yoder, Sean J, Conejo-Garcia, Jose R, Guevara-Patino, Jose A, Bonomi, Marcelo, Bhateja, Priyanka, Rocco, James W, Steuer, Conor E, Saba, Nabil F, Chung, Christine H
منشور في 2022نص -
8
Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort حسب Issa, Majd, Klamer, Brett G., Mladkova, Nikol, Laliotis, Georgios I., Karivedu, Vidhya, Bhateja, Priyanka, Byington, Chase, Dibs, Khaled, Pan, Xueliang, Chakravarti, Arnab, Grecula, John, Jhawar, Sachin R., Mitchell, Darrion, Baliga, Sujith, Old, Matthew, Carrau, Ricardo L., Rocco, James W., Blakaj, Dukagjin M., Bonomi, Marcelo
منشور في 2022نص -
9
Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II St... حسب Chung, Christine H., Bonomi, Marcelo, Steuer, Conor E., Li, Jiannong, Bhateja, Priyanka, Johnson, Matthew, Masannat, Jude, Song, Feifei, Hernandez-Prera, Juan C., Wenig, Bruce M., Molina, Helen, Farinhas, Joaquim M., McMullen, Caitlin P., Wadsworth, J. Trad, Patel, Krupal B., Kish, Julie A., Muzaffar, Jameel, Kirtane, Kedar, Rocco, James W., Schell, Michael J., Saba, Nabil F.
منشور في 2021نص -
10
Phase II multi-institutional clinical trial result of concurrent cetuximab and nivolumab in recurrent and/or metastatic head and neck squamous cell carcinoma حسب Chung, Christine H., Li, Jiannong, Steuer, Conor E., Bhateja, Priyanka, Johnson, Matthew, Masannat, Jude, Poole, Maria I., Song, Feifei, Hernandez-Prera, Juan C., Molina, Helen, Wenig, Bruce M., Kumar, Sunil, Kuperwasser, Charlotte, Stephens, Philip J., Farinhas, Joaquim M., Shin, Dong M., Kish, Julie A., Muzaffar, Jameel, Kirtane, Kedar, Rocco, James W., Schell, Michael J., Saba, Nabil F., Bonomi, Marcelo
منشور في 2022نص